05B4 Alpdogan, Seyfettin Onder - Thomas Jefferson University - Thomas Jefferson University
Dr. Alpdogan

S. Onder Alpdogan, MD

Contact Dr. Alpdogan

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation
  2. Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease
  3. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
  4. STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
  5. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation
  6. Organ-derived dendritic cells have differential effects on alloreactive T cells
  7. IFN-γ and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease
  8. Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity
  9. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation
  10. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stein cell transplantation
  11. DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation
  12. Molecular imaging reveals skeletal engraftment sites of transplanted bone marrow cells
  13. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration
  14. Absence of β7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine
  15. Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation
  16. CCR2 is required for CD8-induced graft-versus-host disease
  17. IL-15: Targeting CD8+ T cells for immunotherapy
  18. Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells
  19. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation
  20. IL-7 and IL-15: Therapeutic cytokines for immunodeficiency
0